Business Context and Reporting Period
Insperity, Inc. filed this Form 8-K on November 3, 2025. The filing reports two primary events: the entry into a material definitive agreement regarding medical coverage and the issuance of a press release announcing financial results for the quarter ended September 30, 2025.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) containing the company's financial and operating results for the quarter ended September 30, 2025. However, the specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity are not included in the body of this Form 8-K. The filing explicitly states that the information in Item 2.02 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Material Changes and Agreements
On November 3, 2025, a subsidiary of Insperity, Inc. amended its medical coverage arrangement with UnitedHealthcare. Key changes include:
- Cost Savings: Additional expected cost savings beginning in 2026.
- Term Extension: The arrangement is extended through 2028.
- Claim Cost Limits: The Company now has the option to annually elect to limit its responsibility for each participant's claim costs to $500,000, $750,000, or $1,000,000 per year.
- Administrative Costs: Revisions to certain administrative costs payable by the Company.
- Incentives: Addition of volume-based incentives subject to certain conditions.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary, or risk factors within the text provided. It notes that the amendment to the UnitedHealthcare agreement includes conditions for volume-based incentives. The financial results referenced in Item 2.02 are incorporated by reference from a separate press release, which is not included in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue, earnings, and cash flow figures.
- Examine Exhibit 10.1 for the full terms of the UnitedHealthcare amendment, including the specific conditions for volume-based incentives and the exact nature of revised administrative costs.
- Verify the impact of the new claim cost limit options ($500k-$1M) on future liability exposure.
- Confirm the timeline and magnitude of the expected cost savings starting in 2026.